1,720,990 research outputs found
Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide.
No full textTo evaluate the different contributions of either microsomal FAD-containing ( FADM ) or cytochrome P-450 dependent monooxygenases in the bioactivation and liver toxicity of thioacetamide-S-oxide ( TASO ) (a proximate metabolite of the liver toxin and carcinogen thioacetamide), this compound: (i) was given to rats pretreated with methimazole (a substrate and inhibitor of FADM ), SKF 525-A (an inhibitor of cytochrome P-450) and cobalt protoporphyrin IX (a synthetic porphyrin which induces a long-lasting depletion of the hepatic cytochrome P-450); and (ii) was added to liver microsomes performing oxidation of model FADM or cytochrome P-450 substrates. Whereas the prior administration of methimazole alleviated the TASO induced liver necrosis, SKF 525-A was almost ineffective. Also pretreatment with cobalt protoporphyrin IX prevented liver necrosis. However, this porphyrin derivative was found to depress both cytochrome P-450 dependent and the FADM dependent biotransformations. On the other hand, addition of TASO to liver microsomes in vitro induced changes in the kinetics of S-oxidation of thiobenzamide and of N-oxidation of dimethylaniline, whereas the O-deethylation of ethoxycoumarin was unchanged. The overall results show the necessity of TASO bioactivation by mixed-function monooxygenases for the toxic action to be apparent; at the same time, the findings suggest FADM as the system mainly involved in TASO metabolism
Methimazole-induced modulation of thiobenzamide bioactivation and toxicity.
No full textThe formation of thiobenzamide-S-oxide (TBSO) from thiobenzamide (TB) by rat liver microsomes was competitively inhibited by methimazole (MMI; 1-methyl-2-mercaptoimidazole), a known substrate and inhibitor of the microsomal FAD-containing monooxygenase. S-oxidation was also temporarily depressed in liver microsomes obtained from MMI-treated rats. When administered in vivo, MMI alleviated TB-induced liver necrosis in a dose-dependent manner; moreover, a significant decrease in the serum concentration of TBSO was observed. The protective effect of MMI against the necrogenic effect of TB could arise from competition of these two chemicals for the same bioactivating system, leading to a lower production of the liver damaging metabolite, TBSO
A quantitative cytochemical study of isolated epithelial cells of the hamster cheek pouch
No full textCircadian rhythm of dry mass and weight-class-pattern of the rat hepatocytes--effects of light-dark and feeding regimens.
No full text1. Dry weight has been determined of individual hepatocytes isolated from rats kept at natural or at reversed daily light-dark cycle, and from rats under time-restricted feeding. Behaviours of liver weight, mitotic activity and binuclearity frequency of the hepatocytes and serum corticosterone have been also investigated. 2. At natural light-dark cycle, liver weight, hepatocyte mitotic activity, and serum corticosterone were higher during the day than during the night. In accordance, dry weight and class number of the hepatocytes were both higher by day than by night. 3. By reversal of the light-dark cycle, circadian rhythms of liver weight, hepatocyte mitotic activity and serum corticosterone underwent a reversal. In accordance, circadian rhythm also reversed of both dry mass of the hepatocytes, which became heavier by night than by day, and pattern of the hepatocyte weight-classes, which became sharper, more discrete and more numerous by night, less defined and lower in number by day. 4. Feeding restriction to early morning or to late afternoon did not affect substantially the circadian rhythms of the parameters examined. 5. Binuclear cell frequency did never differ significantly at midnight with respect to midday, irrespectively to the experimental condition. 6. Regulation of the circadian rhythm of both weight-class pattern and dry mass of the hepatocytes appears to be mainly acted by the light-dark regimen likely via modulation of the plasma glucocorticoids (corticosterone) concentration, and increase/decrease of which causes a decrease/increase of the total solid content of hepatocytes, with redistribution of cells in the weight-classes. 7. Feeding rhythm and time elapsed from food intake mainly influence definition of the individual weight-classes and weight range of the hepatocytes
Biliary cirrhosis and tumors induced by chronic administration of thiobenzamide to rats.
No full textThiobenzamide (TB), a thiono-containing compound, was administered for 38 weeks to female Sprague-Dawley rats at a dose of 1 g/kg standard diet; the resulting liver pathology was followed up to 8 months after withdrawal of the compound from the diet. TB administration induced the appearance of biliary cirrhosis. In the first weeks of intoxication the progressive distortion of the liver architecture was mainly due to significant proliferation of the bile ductules. Later, the liver assumed a macronodular appearance. In addition to regenerative and degenerative changes of the hepatocytes, preneoplastic lesions were also detected, and some enzymic markers of the mixed-function monooxygenase system were decreased. Cholangiofibrotic areas were evident, and many biliary tubules within them showed mucous metaplasia. At the end of the intoxication period, as well as 4 months after drug suspension, large portions of the liver or entire lobes were substituted by connective tissue surrounding nests of bile ductules and atrophied hepatocellular nodules. Four months later, in the virtual absence of cirrhotic changes, each animal harboured one or more tumors (mainly cholangiomas)
Early biochemical liver changes following thiobenzamide poisoning
No full textAdministration of thiobenzamide in a single dose (25 mg/100 g body wt by stomach tube) to male rats induced centrilobular necrosis, which became evident 10 h after the poisoning. In the meantime liver weight and water content underwent changes, glycogen was lost, triglycerides accumulated in the liver while decreasing in serum, [3H]leucine uptake in proteins was impaired and the activity of glucose-6-phosphatase and aminopyrine demethylase decreased. The activity of NADPH-cytochrome c reductase remained unchanged, whereas a reduction of the microsomal cytochrome P-450 occurred. The liver amount of reduced glutathione underwent no significant changes. Pretreatment of the animals with cobalt chloride or 20-methylcholanthrene decreased the liver damage caused by the drug. The in vitro addition of thiobenzamide to liver microsomes resulted in a spectral change. The appearance of conjugated dienes among microsomal lipids from drug-treated rats indicated for a lipoperoxidation taking place in vivo
Liver cell proliferation induced by single administration of thiobenzamide.
No full textAfter administration of thiobenzamide (TB) (2.5 mg/100 g b.w.) by stomach tube to male rats, an increase of liver weight was evident within 2 days. It was associated with an increase of hepatic DNA, in the incorporation of [3H]thymidine into nuclei of both hepatocytes and bile duct cells and also in the mitotic index of both types of cells. Liver water content and morphology as well as serum GPT activity were unchanged. In conclusion, TB administration in a single dose below the necrotic threshold stimulates multiplication of liver cells without evidence of damage
Promotive effects of thiobenzamide on liver carcinogenesis.
No full textThiobenzamide (a thiono-sulfur-containing xenobiotic), when administered to male Sprague-Dawley rats primed with a single low dose of diethylnitrosamine, enhances the number and size of both gamma-glutamyltranspeptidase-positive hepatocellular foci and cholangiofibrotic areas. Its effect seems to be greater than that of the known promoter phenobarbital
Changes in the rat liver drug metabolizing system during a short thiobenzamide feeding cycle.
No full textThe changes in the hepatic drug metabolizing enzymes induced by the liver tumor promoter thiobenzamide (TB) were investigated. Feeding of TB to rats at a promoting regimen (1 g/kg of diet for 2 weeks) resulted in a significant decrease in the amount of liver microsomal cytochrome P-450 and of total heme. Also, the activity of cytochrome P-450 dependent monooxygenases (aminopyrine demethylase, arylhydrocarbonmonooxygenase and ethoxycoumarindeethylase) and FAD-containing monoxygenase (N,N-dimethylaniline N-oxidase and TB S-oxidase) were depressed. By contrast, phase II enzymes such as epoxide hydrase, UDP-glucuronyl transferase and GSH-transferase were significantly induced. This overall change in the drug metabolizing system was associated with tolerance of the liver towards a high necrogenic dose of TB itself as well as with an increase of mitoses and apoptosis of the hepatocytes. The findings suggest a possible relationship between this TB-induced adaptive response and the promoting activity of the compound on liver carcinogenesis
Characterization of the promoting activity of thiobenzamide on liver carcinogenesis.
No full textTo characterize the promoting activity of thiobenzamide (TB), a thiono-sulfur-containing xenobiotic, rats of both sexes were treated with the compound for 4 or 8 weeks after an initiating dose of diethyl-nitrosamine. The number, area (volume), and phenotypic complexity of the enzyme-altered hepatocyte foci were studied in serial sections stained with hematoxylin/eosin and reacted for glycogen, iron, and gamma-glutamyltranspeptidase activity. The TB-induced changes on the drug metabolizing systems were also investigated. The main findings were: When fed in a dose range of 500-2,000 mg/kg of diet, TB induced a number of foci greater than controls, especially in female rats. Benzamide, a major TB metabolite, was ineffective. The appearance of hepatocyte foci upon TB feeding was nearly synchronized. An increase of the phenotypic complexity of the hepatocyte foci occurred only during the first 4 weeks of TB administration; it correlated with an increase in size. The liver microsome content of cytochrome P-450 as well as the activity of many monooxygenases was decreased, some of the phase II reactions being increased. In conclusion TB behaves as an efficient promoter of liver carcinogenesis, possibly as a consequence of an induced adaptive response
- …
